Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) major shareholder Bain Capital Investors Llc purchased 5,480,052 shares of the stock in a transaction that occurred on Monday, October 16th. The stock was purchased at an average price of $22.81 per share, for a total transaction of $124,999,986.12. Following the acquisition, the insider now owns […]
Piper Sandler initiated coverage on shares of Cerevel Therapeutics (NASDAQ:CERE – Free Report) in a research report report published on Wednesday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $33.00 price objective on the biotechnology company’s stock. CERE has been the subject of a number of other reports. Bank of America […]
Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE) Receives $34 00 Average Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Profund Advisors LLC purchased a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 39,316 shares of the biotechnology company’s stock, valued at approximately $959,000. Other hedge funds and other institutional […]
Insider Buying: Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE) Insider Purchases $501,708 40 in Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.